New Zealand - Export of Heparin for Therapeutic Use
Since 2014, New Zealand Export of Heparin for Therapeutic Use fell by 3.7% year on year. At $5,796,837.1 in 2019, the country was number 24 among other countries in Export of Heparin for Therapeutic Use. New Zealand is overtaken by Argentina, which was ranked number 23 with $5,967,839.45 and is followed by Austria at $5,291,062.18. China topped the ranking with $1,237,456,257.9 in 2019, that is -3% compared to 2018. United States, France and Singapore respectively ranked number 2, 3 and 4 in this ranking. Montenegro recorded the best 5 years average growth at +490.8% per year, while Greenland witnessed the worst performance at -78.9% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 5,796,837.10 |
| 2018 | 6,504,064.00 |
| 2017 | 3,592,539.75 |
| 2016 | 4,366,201.00 |
| 2015 | 3,625,524.00 |
Download all data from 1989 to 2019
How does New Zealand rank in Export of Heparin for Therapeutic Use?
| # | 108 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
China
|
1,237,456,257.90 | 2019 | -3.0 % | +6.7 % | View data | |
| 2 |
#2
United States
|
528,184,315.05 | 2019 | +3.8 % | -15.3 % | View data | |
| 23 |
#23
Argentina
|
5,967,839.45 | 2019 | +29.4 % | -14.8 % | View data | |
| 24 |
#24
New Zealand
|
5,796,837.10 | 2019 | -10.9 % | -3.7 % | View data | |
| 25 |
#25
Austria
|
5,291,062.18 | 2019 | -18.5 % | +18.1 % | View data | |